PAW by Blackmores Hepatoadvanced for Cats and Small Dogs under 15kg - 60 Tablets

NEW & IMPROVED!

In this NEW formulation PAW By Blackmore’s have improved the ease of administration without compromising on therapeutic efficiency. PAW achieved this by crafting a smaller and easier-to-give format that aids in the management of compromised liver biomarkers in cats and dogs.

Enhance your pet's liver health with PAW Hepatoadvanced, a concentrated antioxidant supplement specially designed for cats and small dogs. This unique formula aids in managing compromised biomarkers of the liver, promoting detoxification and overall well-being.

It is advisable to seek the opinion of a veterinarian both before and during the use of this product to tailor it to the specific needs of your pet. If your pet is currently on behavioral medication, consult your vet before introducing Hepatoadvanced.

Features & Benefits:

• Tasty, chewable tablet presentation
• Simple and convenient dosing
• Supports glutathione production
• Promotes liver detoxification
• Helps mitigate negative side effects of certain medications on the liver
• Supports the liver in cases of acute liver toxicity
• Promotes proper brain function in dogs
• Formulated with delayed-release technology for steady metabolism and prolonged activity
• Stable form of S-adenosyl-L-methionine (SAMe) supports vital metabolic pathways, modulating cytokine expression, diminishing cholestasis, and regulating apoptosis.
• Silybin in a phospholipid complex enhances bioavailability, increasing biliary flow, inhibiting leukotriene production, modifying membrane function, and restoring antioxidant enzyme expression and activity.
• Vitamin E promotes cell proliferation, modulates gene expression, and regulates cell signaling pathways dependent on reactive oxygen intermediates.

Hepatoadvanced can be used as an adjunctive therapy for conditions like:

• Chronic hepatitis
• Hepatic lipidosis
• Cholangiohepatitis
• Paracetamol toxicity
• Hepatotoxic mushroom ingestion
• Copper-related hepatopathy
• Iron overload (Note: does not prevent corticosteroid-induced hepatic vacuolar change)
• Metabolic hepatopathies
• Other acute or chronic hepatopathies
• Neoplasia
• Canine cognitive dysfunction
• Cirrhosis

Active Ingredients:

S-Adenosyl-L-methionine disulfate p-toluenesulfonate (equiv. to SAMe) 50 mg, D-alpha tocopherol succinate (Vitamin E) 45 IU, Silybin Phospholipids (equiv. to silybin A+B) 13 mg

Note:

• Hepatoadvanced can be used in conjunction with other hepatic treatments, including prescription diets, ursodeoxycholic acid, anti-inflammatories, and non-vitamin E containing nutritional supplements.
• Regular re-assessment (e.g., every 1-3 months) is recommended to ensure the optimal dose for the desired therapeutic outcome.
• Safe use in pregnant or lactating animals has not been established.

ADMINISTRATION:

Cat/Dog Weight:            Dosage:

1-2.4kg                           1 Tablet

2.5-9.9kg                        2 Tablets

10-14.9kg                       3 Tablets